JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 33:350-357
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kikushima, S.
Right arrow Articles by Katagiri, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kikushima, S.
Right arrow Articles by Katagiri, T.

CLINICAL STUDIES

Triggering mechanism for neurally mediated syncope induced by head-up tilt test

Role of catecholamines and response to propranolol

Shuji Kikushima, MDa, Youichi Kobayashi, MDa, Haruyuki Nakagawa, MDa and Takashi Katagiri, MDa

a Third Department of Internal Medicine, Showa University School of Medicine 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan

Manuscript received March 16, 1998; revised manuscript received July 16, 1998, accepted October 6, 1998.

Reprint requests and correspondence: Dr. Youichi Kobayashi, Third Department of Internal Medicine, Showa University School of Medicine, 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan

OBJECTIVES

We studied the triggering mechanism for neurally mediated syncope.

BACKGROUND

Although increased transient sympathetic tone is thought to be necessary for the development of neurally mediated syncope, little is known about the triggering mechanism for neurally mediated syncope.

METHODS

Plasma epinephrine (EP) and norepinephrine (NE) levels were assessed in 20 syncope patients during tilt test (80°, 15 min) with and without isoproterenol (ISP, 0.01, 0.02 µg/kg/min). If syncope occurred, propranolol (0.1 mg/kg) was injected.

RESULTS

Eight patients experienced syncope during tilting alone, and 9 patients required ISP for syncope. In the negative response without ISP, NE showed a small statistical 1.7-fold increase at end of tilting and EP did not change during tilting. When syncope occurred during tilting alone, a significant 11.7-fold increase in EP at syncope was registered concomitant with a small 2.5-fold increase in NE. When patients experienced syncope during tilting with ISP, a significant 5.0-fold increase in EP at syncope was registered concomitant with a small 1.7-fold increase in NE. In patients without ISP, propranolol did not interrupt syncope. In patients with ISP, six of eight receiving propranolol responded to tilting negatively.

CONCLUSIONS

An increase of NE levels may result in inhibition of syncope and an EP surge may be a triggering mechanism for neurally mediated syncope. Comparatively low levels of EP may be enough to induce syncope during tilting with ISP compared with tilting alone. Propranolol is not effective in patients without ISP, but it frequently inhibits syncope in patients with ISP. Propranolol (0.1 mg/kg) may be insufficient to block the actions of high levels of circulating EP.

Abbreviations and Acronyms
  BP = blood pressure
  CA = catecholamine
  ECG = electrocardiogram
  EP = epinephrine
  HR = heart rate
  HUT = head-up tilt test
  ISP = isoproterenol
  NE = norepinephrine
  NMS = neurally mediated syncope
  PROP = propranolol




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. P. Moak, J. J. Bailey, and F. T. Makhlouf
Simultaneous heart rate and blood pressure variability analysis: Insight into mechanisms underlying neurally mediated cardiac syncope in children
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1466 - 1474.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.